<code id='19C317E60F'></code><style id='19C317E60F'></style>
    • <acronym id='19C317E60F'></acronym>
      <center id='19C317E60F'><center id='19C317E60F'><tfoot id='19C317E60F'></tfoot></center><abbr id='19C317E60F'><dir id='19C317E60F'><tfoot id='19C317E60F'></tfoot><noframes id='19C317E60F'>

    • <optgroup id='19C317E60F'><strike id='19C317E60F'><sup id='19C317E60F'></sup></strike><code id='19C317E60F'></code></optgroup>
        1. <b id='19C317E60F'><label id='19C317E60F'><select id='19C317E60F'><dt id='19C317E60F'><span id='19C317E60F'></span></dt></select></label></b><u id='19C317E60F'></u>
          <i id='19C317E60F'><strike id='19C317E60F'><tt id='19C317E60F'><pre id='19C317E60F'></pre></tt></strike></i>

          focus

          focus

          author:focus    Page View:7
          Blood samples
          Marion Berard/AFP/GettyImages

          With the advent of disease-modifying Alzheimer’s drugs, everyone in the world of Alzheimer’s diagnostics is bracing for the crush.

          Based on their ability to slow cognitive decline, the Eisai/Biogen drug Leqembi won full approval from the FDA this month, and donanemab by Eli Lilly could be approved by year end. Clinicians now have to decide which patients are most suitable for treatment, which means better Alzheimer’s tests need to be developed.

          advertisement

          “There’s going to be capacity issues because there’s just not enough neurologists in the world to treat this pool of patients with Alzheimer’s disease at the moment,” said Mark Stearman, a senior international product manager at Roche focusing on Alzheimer’s diagnostics.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          leisure time

          Activists slam private health insurers over coverage restrictions
          Activists slam private health insurers over coverage restrictions

          ProtestorsoutsideAmerica'sHealthInsurancePlansheadquarters.CourtesyPeople'sActionWASHINGTON—Hun

          read more
          Doctor appointment wait times are getting worse
          Doctor appointment wait times are getting worse

          SpencerPlatt/GettyImagesIn2004,thephysiciansearchfirmMerrittHawkinsfirstissuedtheirSurveyofPhysician

          read more
          Trump demands the U.S. pay no more for drugs than other countries … again
          Trump demands the U.S. pay no more for drugs than other countries … again

          EthanMiller/GettyImagesWASHINGTON—FormerPresidentTrumpisbacktocampaigningfortyingMedicaredrugpricest

          read more

          A new study asks: Are we harming blood donors by taking blood?

          AphlebotomistcollectvialsofbloodatadonationcenterinSanFrancisco.JustinSullivan/GettyImagesOnequestio